Immix Biopharma, Inc. Quarterly Depreciation in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Immix Biopharma, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2024.
  • Immix Biopharma, Inc. Depreciation for the quarter ending March 31, 2024 was $3.01K, a 496% increase year-over-year.
  • Immix Biopharma, Inc. annual Depreciation for 2023 was $5.47K, a 156% increase from 2022.
  • Immix Biopharma, Inc. annual Depreciation for 2022 was $2.14K, a 13.5% decline from 2021.
  • Immix Biopharma, Inc. annual Depreciation for 2021 was $2.47K, a 6.33% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.01K +$2.51K +496% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $505 -$115 -18.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $620 +$12.00 +1.97% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $608 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.